Slaoui Apologizes For Sexual Harassment, Loses Further Industry Roles
Exits Vaxcyte And Centessa
The former Operation Warp Speed leader has apologized unreservedly for his actions, and loses positions with two biopharma companies.
You may also be interested in...
Pharma firm calls behaviour “wholly unacceptable” after external investigators back up employee allegations.
In an interview with Scrip, CEO Saurabh Saha elaborates on the first-of-its-kind R&D model.
GSK’s PD-1 inhibitor will not be able to make up much ground on Keytruda, but new studies suggest it is a match for the market-leading PD-1 inhibitors.